UBS raises Applied Materials stock price target on supply outlook

Applied Materials reported Q2 fiscal 2026 EPS of $2.86 versus $2.68 expected and record revenue of $7.91B versus $7.68B consensus, while UBS lifted its price target to $515 from $480 and KeyBanc raised its target to $550 from $450. Management’s commentary points to strong multi-year AI-driven semiconductor demand, with wafer fab equipment spending projected at about $200B in 2027 and $250B in 2028. The tone is positive for AMAT, though UBS flagged a likely deceleration in shipment dollar growth in the second half of the year.

Analysis

The key signal is not just that AMAT is executing, but that the semi-capex cycle is shifting from a broad demand rebound to a capacity-constrained, supply-led advance. When shipment growth decelerates despite stronger guidance, it usually means backlog monetization is becoming less important than bottlenecks, which supports pricing power for leading equipment vendors and raises the odds of a longer-duration earnings runway. That is constructive for the whole lithography/etch/deposition stack, but especially for names with high exposure to multi-year capacity builds rather than near-term handset/PC demand.

Second-order winners are the suppliers further up the value chain that feed fab expansion: specialty materials, consumables, and automation vendors should see a more durable order profile if wafer fab spending really stretches into 2027-2029. The flip side is that the market may be underestimating execution risk from cleanroom, labor, and tool-installation constraints; if fabs can’t absorb tools fast enough, near-term shipment timing can slip even while end-demand stays intact. That creates a setup where revenue recognition becomes lumpier and the strongest balance sheets take share from weaker peers.

The consensus may be too focused on the near-term upgrade cycle and not enough on how quickly multiple compression can arrive if the capex narrative fades after the next 1-2 quarters. At ~45x trailing earnings, the stock is already pricing in a lot of durability; the key variable is whether calendar 2028 EPS becomes a believable anchor or turns into a peak-cycle number. If AI infrastructure spend remains concentrated in a few hyperscalers, the broader equipment rally can still overshoot fundamentals, but any pause in AI server buildouts would hit sentiment fast.

The cleanest risk is a timing mismatch: stock can stay bid for months on guide raises and analyst revisions, but the trade is vulnerable if managements across the semi supply chain start talking about normalization in order patterns by late summer. That makes this more of a catalyst-driven momentum long than a deep-value compounder at current levels. The best hedge is to pair strong equipment exposure with a short in a more cyclically stretched semi name or use options to express upside while capping multiple-risk downside.

Key Decisions for Investors

• Stay long AMAT for 4-8 weeks into the next estimate revision cycle, but size modestly: the upside is continuation of upward earnings revisions and AI capex spillover; the downside is multiple compression if shipment growth slows faster than bookings.
• Pair long AMAT / short a higher-beta semi equipment peer with more cyclical exposure for the next quarter; this isolates share gains and reduces risk if the entire group de-rates on macro or capex concern.
• Buy AMAT call spreads 2-4 months out rather than stock if entering after a sharp run; this captures further upward estimate revisions while limiting exposure to a post-earnings pullback from already elevated multiples.
• Add exposure to semi supply-chain beneficiaries on weakness over the next 1-3 months, especially names tied to fab buildouts and consumables, because the capex cycle appears more supply-constrained than demand-constrained.
• Set a tactical take-profit trigger on AMAT if the stock rerates materially above the new target zone without another round of guidance raises; at that point, risk/reward shifts from revision-led upside to narrative exhaustion.